diallyl disulfide has been researched along with Cardiomyopathies in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jia, HZ; Shi, ZX; Zhang, HX | 1 |
Huang, YT; Kuo, WW; Lee, KW; Ou, HC; Tsai, CY; Way, CL; Yao, CH | 1 |
2 other study(ies) available for diallyl disulfide and Cardiomyopathies
Article | Year |
---|---|
[Garlicin ameliorated pressure overload induced myocardial fibrosis in rats through partial inhibiting TGF-beta1 mediated Smads signal].
Topics: Allyl Compounds; Animals; Cardiomyopathies; Disulfides; Fibrosis; Male; Myocardium; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1 | 2012 |
Diallyl trisulfide and diallyl disulfide ameliorate cardiac dysfunction by suppressing apoptotic and enhancing survival pathways in experimental diabetic rats.
Topics: Allyl Compounds; Animals; Apoptosis; Cardiomyopathies; Caspase 3; Cell Survival; Diabetes Mellitus, Experimental; Disulfides; Garlic; Heart; Male; Mitochondria; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Rats; Rats, Wistar; Receptors, Death Domain; Signal Transduction; Sulfides; Superoxide Dismutase; Superoxide Dismutase-1; Tyrosine | 2013 |